Comment on: Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.
作者信息
Sarkar Sandip, Deb Amit Kumar
机构信息
Department of Ophthalmology, Jawaharlal Institute Postgraduate Medical Education and Research, Puducherry, India.
出版信息
Indian J Ophthalmol. 2022 Jun;70(6):2208. doi: 10.4103/ijo.IJO_455_22.
Abstract
摘要
相似文献
1
Comment on: Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.关于“在累及黄斑中心的糖尿病性黄斑水肿中玻璃体内注射抗血管内皮生长因子联合或不联合局部非甾体抗炎药”的评论
Indian J Ophthalmol. 2022 Jun;70(6):2208. doi: 10.4103/ijo.IJO_455_22.
2
Response to comment on: Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.对关于“在累及黄斑中心的糖尿病性黄斑水肿中玻璃体内注射抗血管内皮生长因子联合或不联合局部非甾体抗炎药”评论的回复
Indian J Ophthalmol. 2022 Jun;70(6):2209. doi: 10.4103/ijo.IJO_750_22.
3
Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.玻璃体内抗血管内皮生长因子联合和不联合局部非甾体类抗炎药治疗中心性糖尿病黄斑水肿。
Indian J Ophthalmol. 2021 Nov;69(11):3279-3282. doi: 10.4103/ijo.IJO_1465_21.
4
Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.雷珠单抗治疗伴或不伴糖尿病性黄斑水肿的糖尿病视网膜病变
Ophthalmol Retina. 2020 Oct;4(10):1034-1036. doi: 10.1016/j.oret.2020.05.020. Epub 2020 Jun 5.
5
Real-life anti-vascular endothelial growth factor treatment for age-related macular degeneration and diabetic macular edema in an Italian tertiary referral hospital.意大利一家三级转诊医院中抗血管内皮生长因子治疗年龄相关性黄斑变性和糖尿病性黄斑水肿的真实案例
Eur J Ophthalmol. 2020 Nov;30(6):1461-1466. doi: 10.1177/1120672119880386. Epub 2019 Oct 16.
6
Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema.玻璃体内注射贝伐单抗治疗糖尿病性黄斑水肿后黄斑裂孔的形成
Korean J Ophthalmol. 2019 Apr;33(2):198-199. doi: 10.3341/kjo.2018.0079.
7
Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study).以色列贝伐单抗治疗失败后使用雷珠单抗治疗糖尿病性黄斑水肿（DERBI研究）
Eur J Ophthalmol. 2019 Mar;29(2):229-233. doi: 10.1177/1120672118782102. Epub 2018 Jun 19.
8
IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.长期玻璃体内抗血管内皮生长因子治疗对糖尿病性黄斑水肿中预先存在的微观结构改变的影响。
Retina. 2018 Sep;38(9):1824-1829. doi: 10.1097/IAE.0000000000001788.
9
Clinical Decision-Making when Treating Diabetic Macular Edema Patients with Dexamethasone Intravitreal Implants.使用地塞米松玻璃体内植入物治疗糖尿病性黄斑水肿患者时的临床决策
Ophthalmologica. 2018;240(2):61-72. doi: 10.1159/000486800. Epub 2018 Apr 4.
10
Impact of Posterior Vitreous Detachment on Treatment Outcomes in Diabetic Macular Edema.玻璃体后脱离对糖尿病性黄斑水肿治疗效果的影响
Ophthalmol Retina. 2020 Apr;4(4):452-454. doi: 10.1016/j.oret.2019.12.002. Epub 2019 Dec 9.
引用本文的文献
1
Response to comment on: Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.对关于“在累及黄斑中心的糖尿病性黄斑水肿中玻璃体内注射抗血管内皮生长因子联合或不联合局部非甾体抗炎药”评论的回复
Indian J Ophthalmol. 2022 Jun;70(6):2209. doi: 10.4103/ijo.IJO_750_22.
本文引用的文献
1
Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.玻璃体内抗血管内皮生长因子联合和不联合局部非甾体类抗炎药治疗中心性糖尿病黄斑水肿。
Indian J Ophthalmol. 2021 Nov;69(11):3279-3282. doi: 10.4103/ijo.IJO_1465_21.
Zotero 插件